Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Dermatology
•
Aesthetic Dermatology
Have you used topical rapamycin/sirolimus for TSC-related angiofibromas?
Wataya-Kaneda et al., PMID 27837201
Answer from: at Community Practice
I used it before it was approved for the treatment of vascular lesions and noted that it was effective and safe.
Comments
at North Atlanta Dermatology Duluth
What is the percentage you use? I have not found i...
14607
Sign In
or
Register
to read more
Answer from: at Academic Institution
I have used it in 4 patients, and it is more effective over ablative laser treatment of lesions or fractional ablative laser for better drug delivery.
Sign In
or
Register
to read more
Answer from: at Community Practice
It works well and is very safe.
Sign In
or
Register
to read more
Answer from: at Community Practice
Studies with topical sirolimus demonstrate the safe and effective use of the agent for treatment of TSC-related angiofibromas.
Sign In
or
Register
to read more
25067
25030
25241
28368
Related Questions
What questions are important to ask before performing PDL laser?
For patients on medications that are known to cause photosensitivity, would you counsel them to avoid laser hair removal or laser therapies?
What factors influence your decision to recommend surgical versus non-surgical options for patients with severe skin laxity post-weight loss?
How do you counsel patients who inquire about microplastics in their cosmetics or physician-dispensed products given emerging associations with conditions such as psoriasis, eczema, lupus, and hormonal disruption?
How do you weigh the risks of intraocular eye shields when performing CO2 laser to the eyelids and periocular area?
What criteria do you prioritize when trying to select the most effective exosome products for your patients?
Have you noticed granulomatous reactions becoming more common with the rise in peptide-based and nano-technology topical formulations, along with increased use of resurfacing devices outside of physician oversight?
What recommendations do you provide to patients on isotretinoin about timing of tattoos?
How do you bill cosmetic follow-up appointments?
What’s your immediate post-procedure protocol for fractionated laser resurfacing (i.e., Sciton Pro-fractional Laser)?
What is the percentage you use? I have not found i...